HIV promotes dendritic degeneration by altering microtubule-associated protein
HIV通过改变微管相关蛋白促进树突变性
基本信息
- 批准号:10618573
- 负责人:
- 金额:$ 42.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcquired Immunodeficiency SyndromeAdolescentAffectAgingAutomobile DrivingAutopsyBindingBiologicalBrainBrain DiseasesCentral Nervous System DiseasesCerebral cortexCerebrospinal FluidCognitiveCytoskeletonDataDendritesEventExhibitsGlycoproteinsGoalsGrantHIVHIV Envelope Protein gp120HIV-1HIV-associated neurocognitive disorderHumanImpaired cognitionImpairmentIncidenceInjuryIntermediate FilamentsLeadMeasuresMediatingMental HealthMental disordersMicrofilamentsMicrotubule AlterationMicrotubule-Associated Protein 2Microtubule-Associated ProteinsMicrotubulesModificationMolecularNerve DegenerationNeuraxisNeuritesNeurocognitiveNeuronsOlder PopulationPathologyPerformancePersonsPharmaceutical PreparationsPlayPolymersPost-Translational Protein ProcessingProcessProtein IsoformsRattusReproducibilityRoleStimulusSynapsesTechniquesTestingTubulinViral ProteinsVirusagedaging brainantagonistantiretroviral therapydrug developmenteffective therapyenv Gene Productsimmune activationinnovationknock-downneuroAIDSneuropathologyneurotoxicneurotoxicitynovel markeroverexpressionpreventprotein aggregationtherapeutic targettrafficking
项目摘要
Abstract
Despite antiretroviral therapy (ART), HIV can cause cognitive and mental health disorders, referred to as HIV-
associated neurocognitive disorders (HAND). HAND pathology, which is characterized by synaptodendritic
damage, resembles that observed in aging brain. At present, there are no effective treatments for HAND. In
addition, it has been suggested that anti-retroviral therapy (ART) impairs neuronal function; thus, the
identification of new mechanisms that can lead to a reduction of HIV-mediated neuropathology is important.
The major goal of this project is to discover the biological mechanisms whereby HIV reduces dendrites. Our
preliminary data show that the cerebrospinal fluid (CSF) and postmortem brains of people living with HIV
(PLWH), whose neurocognitive performance is reduced, have a higher content of microtubule-associated
protein 2 (MAP2), when compared to cognitively normal PLWH. MAP2, which is highly enriched in dendrites,
binds to microtubules (MTs) and plays a key role in their formation and elongation, and helps neuronal
trafficking. However, MAP2 has different isoforms that, when accumulate in neurons, they promote impairment
of MTs function and dendritic degeneration. HIV could directly alter MAP2 levels or use viral proteins to impair
the function of MTs. Because the HIV-mediated loss of dendrites is experimentally reproducible by the
envelope glycoprotein gp120, we hypothesize that HIV affects the overall function of dendritic MTs by a gp120-
dependent mechanism which encompasses an alteration of MAP2 binding to MTs. Two Specific Aims are
proposed to test this hypothesis. In Aim 1, we will examine the mechanisms whereby HIV/gp120 alters MAP2.
In Aim 2, we will use various approaches to reduce or enhance MAP2 isoforms and examine their role in
dendritic injury. A better understanding of these mechanisms is instrumental for drug development to reduce
the incidence of HAND.
摘要
尽管有抗逆转录病毒治疗(ART),艾滋病毒可导致认知和精神健康障碍,称为艾滋病毒-
相关的神经认知障碍(HAND)。HAND病理学,其特征在于突触树突
损伤,类似于在老化的大脑中观察到的。目前,HAND尚无有效的治疗方法。在
此外,已经提出抗逆转录病毒疗法(ART)损害神经元功能;因此,
鉴定可导致减少HIV介导的神经病理学的新机制是重要的。
该项目的主要目标是发现HIV减少树突的生物学机制。我们
初步数据显示,艾滋病毒感染者的脑脊液和死后大脑
(PLWH),其神经认知性能降低,具有较高的微管相关蛋白含量。
蛋白2(MAP 2),与认知正常PLWH相比。MAP 2在树突中高度富集,
与微管(MT)结合,在其形成和延伸中起关键作用,并帮助神经元
贩卖人口然而,MAP 2具有不同的亚型,当在神经元中积累时,它们促进损伤
MT功能和树突状细胞退化的证据。HIV可以直接改变MAP 2水平或利用病毒蛋白损害
MT的功能。因为HIV介导的树突缺失在实验上是可重复的,
包膜糖蛋白gp 120,我们假设HIV通过一个gp 120-
依赖性机制,其包括MAP 2与MT结合的改变。两个具体目标是
来检验这个假设。在目标1中,我们将研究HIV/gp 120改变MAP 2的机制。
在目标2中,我们将使用各种方法来减少或增强MAP 2亚型,并检查它们在以下方面的作用:
树突损伤更好地理解这些机制有助于药物开发,
手的发病率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Italo Mocchetti其他文献
Italo Mocchetti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Italo Mocchetti', 18)}}的其他基金
Gp120 binds to neuronal microtubules: a new mechanism for synaptic simplification
Gp120 与神经元微管结合:突触简化的新机制
- 批准号:
9422907 - 财政年份:2017
- 资助金额:
$ 42.9万 - 项目类别:
GPR75: a new CCL5 receptor that mediates neuroprotection against HIV
GPR75:一种新的 CCL5 受体,介导针对 HIV 的神经保护
- 批准号:
8845810 - 财政年份:2014
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration
proBNDF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
10414965 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration
proBDNF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
8551768 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration
proBNDF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
9977267 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration
proBDNF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
8915763 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBNDF and p75NTR in HIV-mediated Axonal/Dendritic Degeneration
proBNDF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
10621350 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration
proBDNF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
8466684 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Role of proBDNF and p75NTR in HIV-mediated axonal/dendritic degeneration
proBDNF 和 p75NTR 在 HIV 介导的轴突/树突变性中的作用
- 批准号:
8721235 - 财政年份:2012
- 资助金额:
$ 42.9万 - 项目类别:
Cellular and molecular mechanisms of gp120 neurotoxicity
gp120神经毒性的细胞和分子机制
- 批准号:
8263182 - 财政年份:2011
- 资助金额:
$ 42.9万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 42.9万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 42.9万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 42.9万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 42.9万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 42.9万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 42.9万 - 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
- 批准号:
03660315 - 财政年份:1991
- 资助金额:
$ 42.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 42.9万 - 项目类别:














{{item.name}}会员




